Results 201 to 210 of about 270,921 (246)

Parallel processing of T cells and natural killer cells to enhance in vivo CAR T cell activity against blood and solid cancers

Clinical &Translational Immunology, Volume 15, Issue 9, 2026.
Abstract Objectives Despite their anti‐cancer properties, natural killer (NK) cells are discarded during CAR T cell manufacturing. NK cells display promising responses as a cell therapy, exhibiting remarkable safety at high doses. Moreover, NK cells have complementary cytokine profiles and distinct antigen‐recognition pathways to supplement CAR T cell ...
Lachlan J Dobson, Patrick W Marron, Ariana HT Drabble, Thiloma D Liyanage, Kristine C Pe, Clare Y Slaney, Barry D Hock, Alexander D McLellan   +7 more
wiley   +1 more source

Recurrent T-lymphoblastic lymphoma in a pediatric patient with bilateral breast and skin involvement: A rare clinical presentation. [PDF]

Ann Med Surg (Lond)
Çalışkan Kamış Ş, Yağcı B.
europepmc   +1 more source

Prolonged molecular control during intermittent reduced‐intensity blinatumomab maintenance in a transplant‐ineligible patient with Philadelphia chromosome‐positive acute lymphoblastic leukaemia and IKZF1 deletion

Clinical &Translational Immunology, Volume 15, Issue 9, 2026.
Abstract Objectives Long‐term disease control in transplant‐ineligible patients with high‐risk Philadelphia chromosome‐positive acute lymphoblastic leukaemia (Ph+ ALL) remains difficult, particularly when adverse genetic lesions and acquired kinase domain mutations coexist.
Xiaoqian Duan, Jinjun Yang, Yufei Yang, Shuwen Guo, Yu Wu   +4 more
wiley   +1 more source

Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence

Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
This schematic demonstrates how tissue and liquid biopsies facilitate ADC target selection. (A) Demonstrating the tumour microenvironment and the systemic dissemination of CTCs. The primary tumour, nesting a complex microenvironment of immune and stromal cells, shed tumour cells into the bloodstream, facilitating haematogenous spread.
Vahid Yaghoubi Naei, Mehran Dabiri, Lihua Chen, Jiajia Li, I‐Han Wang, Gungun Lin, Majid Ebrahimi Warkiani   +6 more
wiley   +1 more source

Daratumumab plus bortezomib and dexamethasone as a bridge to allogeneic transplantation in refractory T-cell lymphoblastic lymphoma. [PDF]

Ann Hematol
Maraglino AME, Sammassimo S, Lolli G, Clemente A, Tabanelli V, Pastano R, Derenzini E.   +6 more
europepmc   +1 more source

DinoFlow: Self‐supervised pretraining in flow cytometry enables accurate detection of common hematopathological disorders

Cytometry Part B: Clinical Cytometry, Volume 110, Issue 5, Page 347-358, September 2026.
Abstract Flow cytometry is an essential component of routine hematological lab testing. Many computational methods have been proposed for the analysis of flow cytometry data, but most have focused on supervised learning for just one or a few specific disorders.
Brendan O'Fallon, Muir Morrison, Mattia Medina Grespan, Nicholas C. Spies, David P. Ng   +4 more
wiley   +1 more source

Triple-hit TdT-positive high-grade B-cell lymphoma mimicking B-lymphoblastic lymphoma and exhibiting immunophenotypic change at relapse. [PDF]

J Clin Exp Hematop
Saito A, Isoda A, Terasaki Y, Iriuchishima H, Mihara M, Suzuki T, Matsumoto M, Karube K.   +7 more
europepmc   +1 more source

DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis

Hematological Oncology, Volume 44, Issue 5, September 2026.
ABSTRACT BCL6 is a master transcriptional regulator of germinal center (GC) B cells. BCL6 is frequently translocated at the major translocation cluster (MTC) within intron 1 of the BCL6 locus, a hotspot commonly rearranged in diffuse large B cell lymphomas (DLBCLs).
Santosh Kumar Gothwal, Kyoko Oichai, Hongtae Kim, Kyungjae Myung, Jacqueline H. Barlow   +4 more
wiley   +1 more source

Association of Childhood Acute Leukemia With Autoimmune Diseases

International Journal of Cancer, Volume 159, Issue 5, Page 1188-1195, 1 September 2026.
A possible link exists between various pediatric autoimmune diseases (AIDs) and increased risk of childhood leukemia. Although immune dysregulation is a key feature of these conditions, the connection between them remains unclear. In this study, using cancer registry data in Finland, the authors examined associations between AIDs and childhood acute ...
Ida Pellikka, Julia Ventelä, Anssi Auvinen, Olli Lohi, Atte Nikkilä   +4 more
wiley   +1 more source

A Case of Cutaneous B Lymphoblastic Lymphoma With Multiple Cutaneous Tumors

JEADV Clinical Practice, Volume 5, Issue 3, Page 963-966, September 2026.
ABSTRACT A 17‐year‐old Japanese male patient was referred to our hospital due to an erythematous tumor on part of the right mandible that had developed 3 months earlier, and similar tumors had appeared on the trunk and lower extremities. A complete blood count showed no specific abnormalities.
Tomomichi Shimizu, Akio Kondoh, Fumikazu Yamazaki, Osamu Yamamoto, Tomotaka Mabuchi   +4 more
wiley   +1 more source